Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Electrical synapses, particularly gap junctions composed of connexin (Cx) 36, have been suggested to synchronize neuronal network oscillations. Recently, we generated
Cx30.2
-deficient mice which express beta-galactosidase under control of
Cx30.2
gene regulatory elements. In the central nervous system beta-galactosidase activity representing
Cx30.2
expression was restricted to NeuN-positive cells, thus identifying
Cx30.2
as new neuronal connexin. In the hippocampus, co-immunofluorescence analyses revealed beta-galactosidase/
Cx30.2
expression in GABAergic inhibitory interneurons such as parvalbumin- and
somatostatin
-positive basket, axo-axonic, bistratified or oriens lacunosum-moleculare cells. approximately 94% of the
Cx30.2
expressing parvalbumin-positive interneurons also expressed Cx36. Performing field potential recordings from hippocampal slices we found no differences in basal excitation and excitation-inhibition balance between Cx30.2+/+ and Cx30.2LacZ/LacZ)mice. Furthermore, frequency and power of gap junction dependent gamma and ripples oscillations were similar in these animals. This suggests that the lack of
Cx30.2
in interneurons can be largely compensated by other connexins, most likely Cx36.
...
PMID:Expression of connexin30.2 in interneurons of the central nervous system in the mouse. 1794 21